Skip to content
  • Field of application
    • Agrofood
    • Biomedical/pharma
    • Environment/sustainability
    • Personal/public health
    • Veterinary science
  • Focus on
    • Discovery & research
    • Finance & investment
    • Industrial application
    • Technology & digital innovation
  • Content type
    • Article
    • Interview
    • News
    • Opinion
    • Press release
  • Showcase
    • BioVox
    • Biovia
    • QbD Group
    • V-Bio Ventures
    • SciMingo
    • JnJ Innovative Medicine
  • Regional news
    • Belgium
      • Flanders
      • Wallonia
    • Luxembourg
    • The Netherlands
  • Field of application
    • Agrofood
    • Biomedical/pharma
    • Environment/sustainability
    • Personal/public health
    • Veterinary science
  • Focus on
    • Discovery & research
    • Finance & investment
    • Industrial application
    • Technology & digital innovation
  • Content type
    • Article
    • Interview
    • News
    • Opinion
    • Press release
  • Showcase
    • BioVox
    • Biovia
    • QbD Group
    • V-Bio Ventures
    • SciMingo
    • JnJ Innovative Medicine
  • Regional news
    • Belgium
      • Flanders
      • Wallonia
    • Luxembourg
    • The Netherlands
Subscribe
  • Calendar
  • About
    • Learn more about BioVox
  • Contact
  • Calendar
  • About
    • Learn more about BioVox
  • Contact
Subscribe
  • Calendar
  • About
    • Learn more about BioVox
  • Contact
  • Calendar
  • About
    • Learn more about BioVox
  • Contact
  • Field of application
    • Agrofood
    • Biomedical/pharma
    • Environment/sustainability
    • Personal/public health
    • Veterinary science
  • Focus on
    • Discovery & research
    • Finance & investment
    • Industrial application
    • Technology & digital innovation
  • Content type
    • Article
    • Interview
    • News
    • Opinion
    • Press release
  • Showcase
    • BioVox
    • Biovia
    • QbD Group
    • V-Bio Ventures
    • SciMingo
    • JnJ Innovative Medicine
  • Regional news
    • Belgium
      • Flanders
      • Wallonia
    • Luxembourg
    • The Netherlands
  • Field of application
    • Agrofood
    • Biomedical/pharma
    • Environment/sustainability
    • Personal/public health
    • Veterinary science
  • Focus on
    • Discovery & research
    • Finance & investment
    • Industrial application
    • Technology & digital innovation
  • Content type
    • Article
    • Interview
    • News
    • Opinion
    • Press release
  • Showcase
    • BioVox
    • Biovia
    • QbD Group
    • V-Bio Ventures
    • SciMingo
    • JnJ Innovative Medicine
  • Regional news
    • Belgium
      • Flanders
      • Wallonia
    • Luxembourg
    • The Netherlands
Picture of BioVox

BioVox

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is powered by Biovia: the health innovation cluster for Flanders.
Picture of BioVox

BioVox

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is powered by Biovia: the health innovation cluster for Flanders.
  • May 19, 2016

CDK4/CDK6 inhibitors show great promise for breast cancer treatment

  • for BioVox
  • May 18, 2016

Protect what’s yours!

  • for BioVox
  • May 17, 2016

Connected Medicine: Amplified by Simulation

  • for BioVox
  • May 17, 2016

GlycoDelete: the road to plant-grown pharmaceuticals

  • for BioVox
  • May 17, 2016

First map of the Belgian microbiome

  • for BioVox
  • May 17, 2016

From Belgium to NYC and starting a ‘super sniffer’ company

  • for BioVox
  • May 17, 2016

ALS: A fierce diagnosis

  • for BioVox
  • May 17, 2016

Diagnosis on your smartphone!

  • for BioVox
  • May 12, 2016

Europe approves Opdivo-Yervoy immuno combination for melanoma

  • for BioVox
  • May 11, 2016

Indian Patent Office overturns Sovaldi ruling

  • for BioVox
  • May 10, 2016

Algae: the new gold?

  • for BioVox
  • May 10, 2016

Confo Therapeutics appoints Galapagos veteran as CSO

  • for BioVox
  • May 10, 2016

NewLink’s IMPRESS results disappoint

  • for BioVox
  • May 6, 2016

Wave & Pfizer begin metabolic disease collaboration

  • for BioVox
  • May 6, 2016

CRISPR company Intellia prices IPO

  • for BioVox
Previous Next

Follow us on

Icon-linkedin Facebook Icon-x Instagram

Stay updated on the latest news!

Subscribe

Want to contact us?

Contact

Interested in our media kit?

Media kit

Stay updated on the latest news!

Subscribe

Want to get in touch?

Contact Us

Follow us on

Icon-linkedin
©2026 BioVox. All rights reserved.
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}